In last trading session, Checkpoint Therapeutics Inc (NASDAQ:CKPT) saw 0.61 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level of $1.58 trading at $0.1 or 6.76% at ring of the bell on the day assigns it a market valuation of $56.39M. That closing price of CKPT’s stock is at a discount of -129.11% from its 52-week high price of $3.62 and is indicating a premium of 17.72% from its 52-week low price of $1.30. Taking a look at company’s average trading volume volume of 400.98K if we extend that period to 3-months.

Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information

Upright in the green during last session for gaining 6.76%, in the last five days CKPT remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $1.58 price level, adding 6.89% to its value on the day. Checkpoint Therapeutics Inc’s shares saw a change of -31.00% in year-to-date performance and have moved 10.49% in past 5-day. Checkpoint Therapeutics Inc (NASDAQ:CKPT) showed a performance of -15.51% in past 30-days.

Checkpoint Therapeutics Inc (CKPT) estimates and forecasts

Statistics highlight that Checkpoint Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -14.13% of value to its shares in past 6 months, showing an annual growth rate of 57.73% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.32% during past 5 years.

CKPT Dividends

Checkpoint Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.